THE OPTIMAL TREATMENT APPROACH

Welcome to SHPT Challenges

This website contains information about secondary hyperparathyroidism (SHPT). It is intended to provide information to an international audience outside of the USA.

I confirm that I am a healthcare professional practising outside of the USA.

I confirm that I have read and understood the website’s Privacy policy, Cookie settings and Terms of use.

I am a member of the public

You are now leaving our website and heading to a third-party website that we do not operate. We are not responsible for the content of the third-party website. You are advised to review its privacy policy as it may differ from ours.

Are you sure you want to leave?

Confirm

Cancel

/sites/g/files/brlbcj1106/files/2020-03/Background_Bricks_1400-min-min_1.png

THE OPTIMAL TREATMENT APPROACH WOULD HAVE WHICH PRIMARY CHARACTERISTIC?

/sites/g/files/brlbcj1106/files/2020-03/Bricks_900-min.png

25(OH)D: 25-hydroxyvitamin D; FGF-23: fibroblast growth factor-23; PTH: parathyroid hormone.

SHPT TREATMENT AND MANAGEMENT